Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB

Alvaro Proaño, David P. Bui, José W. López, Nancy M. Vu, Marjory A. Bravard, Gwenyth O. Lee, Brian H. Tracey, Ziyue Xu, Germán Comina, Eduardo Ticona, Daniel J. Mollura, Jon S. Friedland, David A.J. Moore, Carlton A. Evans, Philip Caligiuri, Robert H. Gilman, Lilia Cabrera, Marco Varela, Francisco Vigil-Romani, Jesus ChacaltanaJosé L. Cabrera, Antonio Salas, Felix Llanos, Marcos Ñavincopa, Daniela E. Kirwan, Sumona Datta, Jessica D. Rothstein, Nicole A. Doria, Gustavo Hérnandez-Córdova, Richard Oberhelman, Jorge Coronel, Luz Caviedes, Mirko Zimic, Eyal Oren

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

© 2018 The Authors Background: Cough frequency, and its duration, is a biomarker that can be used in low-resource settings without the need of laboratory culture and has been associated with transmission and treatment response. Radiologic characteristics associated with increased cough frequency may be important in understanding transmission. The relationship between cough frequency and cavitary lung disease has not been studied. Methods: We analyzed data in 41 adults who were HIV negative and had culture-confirmed, drug-susceptible pulmonary TB throughout treatment. Cough recordings were based on the Cayetano Cough Monitor, and sputum samples were evaluated using microscopic observation drug susceptibility broth culture; among culture-positive samples, bacillary burden was assessed by means of time to positivity. CT scans were analyzed by a US-board-certified radiologist and a computer-automated algorithm. The algorithm evaluated cavity volume and cavitary proximity to the airway. CT scans were obtained within 1 month of treatment initiation. We compared small cavities (≤ 7 mL) and large cavities (> 7 mL) and cavities located closer to (≤ 10 mm) and farther from (> 10 mm) the airway to cough frequency and cough cessation until treatment day 60. Results: Cough frequency during treatment was twofold higher in participants with large cavity volumes (rate ratio [RR], 1.98; P =.01) and cavities located closer to the airway (RR, 2.44; P =.001). Comparably, cough ceased three times faster in participants with smaller cavities (adjusted hazard ratio [HR], 2.89; P =.06) and those farther from the airway (adjusted HR, 3.61;, P =.02). Similar results were found for bacillary burden and culture conversion during treatment. Conclusions: Cough frequency during treatment is greater and lasts longer in patients with larger cavities, especially those closer to the airway.
Original languageAmerican English
Pages (from-to)1358-1367
Number of pages10
JournalChest
DOIs
StatePublished - 1 Jun 2018

Fingerprint Dive into the research topics of 'Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB'. Together they form a unique fingerprint.

  • Cite this

    Proaño, A., Bui, D. P., López, J. W., Vu, N. M., Bravard, M. A., Lee, G. O., Tracey, B. H., Xu, Z., Comina, G., Ticona, E., Mollura, D. J., Friedland, J. S., Moore, D. A. J., Evans, C. A., Caligiuri, P., Gilman, R. H., Cabrera, L., Varela, M., Vigil-Romani, F., ... Oren, E. (2018). Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB. Chest, 1358-1367. https://doi.org/10.1016/j.chest.2018.03.006